| Company/Division name | Thermo Fisher Scientific Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2024 |
| Capital investment ($): | 192.5 |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | pipette tip |
| What non-domestic negative factors made offshoring less attractive? | Green considerations, Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy |
| Government Incentive dollar amount: | DoD contract |
